FAGR Fagron SA

Disclosure of received notification of The Capital Group Companies and NN Group NV

Disclosure of received notification of The Capital Group Companies and NN Group NV

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 15 October 2021

Disclosure of received notification of The Capital Group Companies and NN Group NV

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of The Capital Group Companies, Inc. (“CGC”) and NN Group NV

Notification of The Capital Group Companies, Inc.

  • On 14 October 2021, Fagron received a notification that the shareholding of CGC had fallen below the disclosure threshold of 5% on 13 October 2021, as the result of the disposal of voting securities or voting rights.
  • The notification is made by a ‘parent undertaking or a controlling person’.
  • On 13 October 2021, CGC held a total of 2,788,420 voting rights. 1,484,803 voting rights are held by Capital Research and Management Company (“CRMC”) and 1,303,617 voting rights are held by Capital International, Inc.
  • Based on the denominator of 72,960,154 (total number of voting rights), CGC held 3.82% of the total number of voting rights on 13 October 2021.
  • CGC is the parent company of CRMC and Capital Bank & Trust Company (“CB&T”). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. (“CGII”), which in turn is the parent company of four investment management companies (“CGII management companies”): Capital International, Inc., Capital International Limited, Capital International Sàrl and Capital International K.K. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.
  • Neither CGC nor any of its affiliates, own Fagron NV shares for its own account. Rather, the shares reported on this notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.
  • The notification of CGC can be viewed on investors.fagron.com via this .



Notification of NN Group NV

  • On 15 October 2021, Fagron received a notification that the shareholding of NN Group NV had crossed the disclosure threshold of 15% on 13 October 2021 as the result of the acquisition of voting securities or voting rights.
  • The notification is made by a parent undertaking or a controlling person.
  • On 13 October 2021, NN Group NV (indirectly) held a total 11,101,452 voting rights. 8,950,000 voting rights are held by Nationale-Nederlanden Levensverzekering Maatschappij NV, 796,117 voting rights are held by NN Investment Partners BV, 735,335 voting rights are held by NN Investment Partners Belgium SA, 510,000 voting rights are held by Nationale-Nederlanden Schadeverzekering Maatschappij NV and 110,000 voting rights are held by NN Re (Netherlands) NV.
  • Based on the denominator of 72,960,154 (total number of voting rights), NN Group NV (indirectly) held 15.22% of the total number of voting rights on 13 October 2021.
  • The notification of NN Group NV can be viewed on investors.fagron.com via this .



In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information

Karen Berg

Global Investor Relations Manager

Tel. 99

Please open the link below for the press release: 



EN
15/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Fagron SA

 PRESS RELEASE

Fagron publishes its Annual Report 2025

Fagron publishes its Annual Report 2025 Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes its Annual Report 2025 Fagron, the leading global player in pharmaceutical compounding, today publishes its Annual Report 2025, further to its earlier announcement of Fagron's annual financial results for the financial year 2025 on February 12, 2026. The Annual Report is available on Fagron's in both Dutch (official version, including the ESEF-tagged version) and English. It comprises the annual financial report relating to the consolidated f...

 PRESS RELEASE

Fagron publiceert haar Jaarverslag 2025

Fagron publiceert haar Jaarverslag 2025 Gereglementeerde informatieNazareth (België)/Rotterdam (Nederland), 6 maart 2026 – 7:00 CET Fagron publiceert haar Jaarverslag 2025 Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, publiceert vandaag haar Jaarverslag 2025, volgend op de eerdere bekendmaking van Fagron's jaarlijkse financiële resultaten over het boekjaar 2025 op 12 februari 2026.  Het Jaarverslag is beschikbaar op de van Fagron in zowel het Nederlands (officiële versie, inclusief ESEF-getagde versie) als in het Engels. Het Jaarverslag omvat het financieel...

 PRESS RELEASE

Fagron completes acquisition of Vepakum

Fagron completes acquisition of Vepakum Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 3 March 2026 – 7:00AM Fagron completes acquisition of Vepakum Fagron, the leading global player in pharmaceutical compounding, announces the successful completion of its acquisition of Vepakum in Latin America. The transaction, announced in December 2025, was finalized following regulatory clearance from CADE in early February 2026. Vepakum operates two facilities in São Paulo, Brazil, and specializes in high-quality pharmaceutical packaging solutions. The ac...

 PRESS RELEASE

Fagron voltooit overname van Vepakum

Fagron voltooit overname van Vepakum Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 3 maart 2026 – 7:00 Fagron voltooit overname van Vepakum Fagron, de toonaangevende wereldwijde speler in farmaceutische bereidingen, maakt bekend dat de overname van Vepakum in Latijns-Amerika succesvol is afgerond. De transactie, die in december 2025 werd aangekondigd, kon worden voltooid nadat CADE, de Braziliaanse mededingingsautoriteit, in februari 2026 goedkeuring verleende. Vepakum beschikt over twee productiefaciliteiten in São Paulo, Brazilië, en is gespecial...

 PRESS RELEASE

Disclosure of a transparency notification from AOC Pharma S.à r.l.

Disclosure of a transparency notification from AOC Pharma S.à r.l. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 27 02 2026 – 6PM CET Disclosure of a transparency notification from AOC Pharma S.à r.l. Pursuant to the Belgian Act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received a transparency notification from AOC Pharma S.à r.l., dated 24 February 2026. Notification from AOC Pharma S.à r.l. On 24 February 2026, Fagron received a transparency notification from AOC Pharma S.à r.l., informing the Company that its sharehold...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch